Skip to content

LSD: all studies

Page 258 of 282: studies 2,571 to 2,580 of 2,815, newest first. Back to the LSD overview

Research

Occurrence of bufotenin in the Osteocephalus genus (Anura: Hylidae).

Toxicon September 15, 2005 T O G Costa, R A V Morales, J P Brito et al. 16 citations

Bufotenin (5-hydroxy-N,N-dimetyltryptamine) is a tryptamine alkaloid widely spread among anuran families as a component of their chemical defense system, acting as a potent hallucinogenic factor, showing similar activity to LSD upon interaction with the 5HT2 human receptor. This work demonstrates the presence of bufotenin in the skin secretion of three arboreal amphibian species of the...

DOI: 10.1016/j.toxicon.2005.02.006 (opens in new tab) Full text (opens in new tab) Amphibian chemical defenses Frog toxins Amphibian venoms Defensive secretions +16

Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.

Psychopharmacology September 1, 2005 William E Fantegrossi, Andrew W Harrington, Justin R Eckler et al. 72 citations

Few studies have examined the effects of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in vivo. 2C-T-7 was tested in a drug-elicited head twitch assay in mice and in several drug discrimination assays in rats; 2C-T-7 was compared to the phenylisopropylamine hallucinogen R(-)-1-(2,5-dimethoxy-4-methylphenyl)-2aminopropane (DOM) in both assays, with or without pretreatment with the...

Serotonergic/glutamatergic interactions: potentiation of phencyclidine-induced stimulus control by citalopram.

Pharmacology, Biochemistry, and Behavior July 2005 Jerrold C Winter, Justin R Eckler, K C Rice et al.

Previous investigations in our laboratory have found that the stimulus effects of the hallucinogenic serotonergic agonists DOM and LSD are potentiated by phencyclidine [PCP], a non-competitive NMDA antagonist. Also suggestive of behaviorally significant serotonergic/glutamatergic interactions is our finding that stimulus control by both PCP and LSD is partially antagonized by the mGlu2/3...

Evidence for a common biological basis of the absorption trait, hallucinogen effects, and positive symptoms: Epistasis between 5-HT2a and COMT polymorphisms

American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics June 17, 2005 Ulrich Ott, Martin Reuter, Juergen Hennig et al. 96 citations

Absorption represents a disposition to experience altered states of consciousness characterized by intensively focused attention. It is correlated with hypnotic susceptibility and includes phenomena ranging from vivid perceptions and imaginations to mystical experiences. Based on the assumption that drug-induced and naturally occurring mystical experiences share common neural mechanisms, we...

Pagliaros’ Comprehensive Guide to Drugs and Substances of Abuse

American Journal of Health-System Pharmacy February 1, 2005 Peter J. Zed 1 citation

Drug and substance abuse is a major problem in North America. Health care providers who care for patients who abuse drugs and other substances need to have a clear understanding of the health, societal, and economic impact of this problem and an intimate knowledge of the agents of abuse to ensure adequate treatment. Pagliaros' Comprehensive Guide to Drugs and Substances of Abuse was written to...

Modulating the Rate and Rhythmicity of Perceptual Rivalry Alternations with the Mixed 5-HT2A and 5-HT1A Agonist Psilocybin

Neuropsychopharmacology January 26, 2005 Olivia Carter, John D. Pettigrew, Felix Hasler et al. 122 citations

Binocular rivalry occurs when different images are presented simultaneously to corresponding points within the left and right eyes. Under these conditions, the observer's perception will alternate between the two perceptual alternatives. Motivated by the reported link between the rate of perceptual alternations, symptoms of psychosis and an incidental observation that the rhythmicity of...

Synesthesia in Perspective

October 14, 2004 Noam Sagiv 10 citations

Abstract The term synesthesia (Greek; syn = together, aesthesia = sensation) has been used to describe a wide variety of phenomena. Most commonly, it is used to denote a condition in which stimulation in one sensory modality also gives rise to an experience in a different modality. However, conditions involving different qualities within one modality (e.g., when the sight of letter shapes...

DOI: 10.1093/oso/9780195166231.003.0001 (opens in new tab) Synesthesia Modality human–computer interaction Perspective graphical Cognitive psychology +2

Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use.

Drug and Alcohol Dependence October 5, 2004 G K L Butler, A M J Montgomery

The present study investigated characteristics of recreational drug users, especially 'ecstasy' (MDMA) users, in 254 undergraduates. All participants completed a drug history questionnaire (DHQ), the impulsiveness venturesomeness and empathy questionnaire, a novel risk-taking task (Bets16), and 59 also completed the tri-dimensional personality questionnaire (TPQ). DHQ responses allocated...

Club drugs: reasons for and consequences of use.

Journal of Psychoactive Drugs September 2004 Kathleen A Parks, Cheryl L Kennedy

This preliminary descriptive study was designed to assess the reasons, primary contexts, and consequences (physical, psychological, lifestyle) of club drug use in a sample of young adults in a mid-size U.S. city. Fifty young adults (18 to 30 years old) reported on their use of club drugs (Ecstasy, GHB, ketamine, Rohypnol, methamphetamine, LSD) in face-to-face interviews that included...

Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.

Addictive Behaviors June 2004 Andrew Scholey, Andrew C. Parrott, Tom Buchanan et al.

Recreational Ecstasy/MDMA (3,4-methylenedioxymethamphetamine) users often take a variety of psychoactive drugs, but there is little empirical data on how these drug consumption patterns change with greater experience of Ecstasy. The aim of this study was to compare the polydrug usage patterns reported by non-Ecstasy users, novice Ecstasy users, moderate Ecstasy users, and heavy Ecstasy users....